CA2955302C - Methode de prediction du resultat d'un traitement a l'aide d'aflibercept d'un patient suspecte d'etre atteint d'un cancer - Google Patents

Methode de prediction du resultat d'un traitement a l'aide d'aflibercept d'un patient suspecte d'etre atteint d'un cancer

Info

Publication number
CA2955302C
CA2955302C CA2955302A CA2955302A CA2955302C CA 2955302 C CA2955302 C CA 2955302C CA 2955302 A CA2955302 A CA 2955302A CA 2955302 A CA2955302 A CA 2955302A CA 2955302 C CA2955302 C CA 2955302C
Authority
CA
Canada
Prior art keywords
aflibercept
patient
cancer
level
ziv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2955302A
Other languages
English (en)
Other versions
CA2955302A1 (fr
Inventor
Marielle Chiron-Blondel
Diether Lambrechts
Emmanuelle MAGHERINI
Vincent Thuillier
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority claimed from PCT/EP2015/066262 external-priority patent/WO2016008975A1/fr
Publication of CA2955302A1 publication Critical patent/CA2955302A1/fr
Application granted granted Critical
Publication of CA2955302C publication Critical patent/CA2955302C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne l'utilisation de l'interleukine -8 (IL -8) comme biomarqueur pour prédire le résultat du traitement à l'aide d'aflibercept, ou de ziv-aflibercept d'un patient suspecté d'être atteint d'un cancer.
CA2955302A 2014-07-18 2015-07-16 Methode de prediction du resultat d'un traitement a l'aide d'aflibercept d'un patient suspecte d'etre atteint d'un cancer Active CA2955302C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14306172.9 2014-07-18
EP14306172 2014-07-18
PCT/EP2015/066262 WO2016008975A1 (fr) 2014-07-18 2015-07-16 Méthode de prédiction du résultat d'un traitement à l'aide d'aflibercept d'un patient suspecté d'être atteint d'un cancer

Publications (2)

Publication Number Publication Date
CA2955302A1 CA2955302A1 (fr) 2016-01-21
CA2955302C true CA2955302C (fr) 2025-07-29

Family

ID=

Similar Documents

Publication Publication Date Title
US11208461B2 (en) Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
US20210293821A1 (en) Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer by measuring the level of a plasma biomarker
EP3194974B1 (fr) Biomarqueurs de pronostic et prédictifs associés à une thérapie anti-angiogénique d'un cancer colorectal métastatique
WO2014020160A1 (fr) Article de manufacture comprenant de l'aflibercept ou du ziv-aflibercept
HK1233710A1 (en) Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
HK1233710B (en) Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
EP4012413A1 (fr) Hgf comme marqueur de la progression du cancer de l'ovaire